carbostyril has been researched along with Acne in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bémer, P; Corvec, S; Dagnelie, MA; Dréno, B; Guillouzouic, A; Khammari, A; Ruffier d'Epenoux, L | 1 |
| Fujikawa, K; Fujikawa, M; Ikeda, F; Kanayama, S; Kitano, T; Matsumoto, T; Mori, S; Nakamura, A; Okamoto, K; Tabara, K; Tamura, R; Uratsuji, H | 1 |
| Hayashi, N; Nakaminami, H; Nakase, K; Nishijima, S; Noguchi, N; Saita, H; Yoshida, A | 1 |
| Fujikawa, A; Ikeda, F; Ishii, R; Kanayama, S; Kawashima, M; Matsumoto, T; Nakajima, A; Okamoto, K; Takei, K | 1 |
| Kikukawa, Y; Morimoto, H; Murakami, N | 1 |
1 review(s) available for carbostyril and Acne
| Article | Year |
|---|---|
Pharmacological profiles and clinical effects of ozenoxacin lotion for the treatments of acne vulgaris and superficial infection of the skin.
Topics: Acne Vulgaris; Aminopyridines; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Microbial Viability; Multicenter Studies as Topic; Quinolones; Skin Cream | 2016 |
4 other study(ies) available for carbostyril and Acne
| Article | Year |
|---|---|
Should we consider broad-spectrum quinolone antibacterial agent as acne treatment in the antimicrobial resistance era?
Topics: Acne Vulgaris; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Quinolones | 2022 |
Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent.
Topics: Acne Vulgaris; Aminopyridines; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Propionibacterium acnes; Quinolones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2020 |
Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Propionibacterium acnes; Quinolones; Skin; Staphylococcus epidermidis | 2019 |
Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris.
Topics: Acne Vulgaris; Aminopyridines; Anti-Infective Agents; Asian People; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Propionibacterium; Quinolizines; Quinolones; Staphylococcus | 2016 |